1. Home
  2. OCUL vs DEA Comparison

OCUL vs DEA Comparison

Compare OCUL & DEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • DEA
  • Stock Information
  • Founded
  • OCUL 2006
  • DEA 2011
  • Country
  • OCUL United States
  • DEA United States
  • Employees
  • OCUL N/A
  • DEA N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • DEA Real Estate Investment Trusts
  • Sector
  • OCUL Health Care
  • DEA Real Estate
  • Exchange
  • OCUL Nasdaq
  • DEA Nasdaq
  • Market Cap
  • OCUL 1.2B
  • DEA 1.1B
  • IPO Year
  • OCUL 2014
  • DEA 2015
  • Fundamental
  • Price
  • OCUL $7.00
  • DEA $10.79
  • Analyst Decision
  • OCUL Strong Buy
  • DEA Buy
  • Analyst Count
  • OCUL 7
  • DEA 2
  • Target Price
  • OCUL $16.71
  • DEA $12.50
  • AVG Volume (30 Days)
  • OCUL 917.6K
  • DEA 1.3M
  • Earning Date
  • OCUL 03-10-2025
  • DEA 02-25-2025
  • Dividend Yield
  • OCUL N/A
  • DEA 9.90%
  • EPS Growth
  • OCUL N/A
  • DEA N/A
  • EPS
  • OCUL N/A
  • DEA 0.17
  • Revenue
  • OCUL $61,442,000.00
  • DEA $302,121,000.00
  • Revenue This Year
  • OCUL $11.40
  • DEA N/A
  • Revenue Next Year
  • OCUL $13.58
  • DEA $8.91
  • P/E Ratio
  • OCUL N/A
  • DEA $62.68
  • Revenue Growth
  • OCUL 6.45
  • DEA 2.98
  • 52 Week Low
  • OCUL $4.06
  • DEA $10.45
  • 52 Week High
  • OCUL $11.78
  • DEA $14.53
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 31.92
  • DEA 43.14
  • Support Level
  • OCUL $7.14
  • DEA $10.45
  • Resistance Level
  • OCUL $7.42
  • DEA $10.87
  • Average True Range (ATR)
  • OCUL 0.37
  • DEA 0.22
  • MACD
  • OCUL -0.02
  • DEA -0.00
  • Stochastic Oscillator
  • OCUL 0.76
  • DEA 44.67

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About DEA Easterly Government Properties Inc.

Easterly Government Properties Inc is a real estate investment trust. It is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. The company generates all its revenue by leasing its properties to such agencies.

Share on Social Networks: